LN

Investor profile

Lars Nordal Jensen

Accelerator & Chief Investment Officer at BioInnovation Institute (BII)

Lars Nordal Jensen is a Chief Investment Officer at BioInnovation Institute (BII), whose known portfolio counts 25 companies.

Is Lars Nordal Jensen a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

lnj***@***.dkPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Affiliated funds' portfolios

Chief Investment Officer at BioInnovation Institute (BII), whose known portfolio counts 25 companies

  • Cambiotics
  • Mello
  • Beech Biotech
  • NorFalk
  • Visibuilt
  • Aiomic
  • Arcana Bio
  • DARERL
  • DiaSense
  • Droplet IV
  • Fuse Vectors
  • FÆRM
  • and 13 more

Investor Profile

The listing covers sectors Climate, Food and Healthcare, and focus areas AgriTech, Biotech, Clean and Renewable Energy and Clinical Trials. Startups operating in these areas may find Lars Nordal Jensen relevant.

Stage-wise, the deals at BioInnovation Institute (BII) cluster around Pre-Seed and Seed rounds.

What the affiliated firm has backed is the closest available signal on whether Lars Nordal Jensen is worth approaching.

Colleagues at BioInnovation Institute (BII)

Frequently asked questions

Who is Lars Nordal Jensen?

Lars Nordal Jensen is an accelerator partner based in Copenhagen, Denmark, listed as Chief Investment Officer at BioInnovation Institute (BII). The known portfolio of that firm counts 25 companies. That portfolio belongs to the firm, not to Lars Nordal Jensen personally.

What does Lars Nordal Jensen invest in?

Listed sectors include Climate, Food and Healthcare; listed focus areas include AgriTech, Biotech, Clean and Renewable Energy and Clinical Trials. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Lars Nordal Jensen invest at?

BioInnovation Institute (BII) appears in Pre-Seed and Seed rounds across its known deals, and Lars Nordal Jensen is listed there as Chief Investment Officer. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Lars Nordal Jensen listed at?

Lars Nordal Jensen is listed as Chief Investment Officer at BioInnovation Institute (BII). 13 other people in the database share a firm with Lars Nordal Jensen.

How do I contact Lars Nordal Jensen?

An email address, a phone number and a LinkedIn page are on file for Lars Nordal Jensen. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal